Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804570 · ClinicalTrials.gov registry record · Phase 2
A Study for the Treatment of Alcohol Dependence
A Phase 2 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 375
- Enrollment target
NCT00804570 is a Phase 2 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 375 participants.
The verdict
NCT00804570, a Phase 2 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 375 participants
- Enrollment target
Study Summary
The Primary objective of this study is to test whether LY2196044 can reduce the number of heavy drinking days per month in people with alcohol dependence. Each subject will undergo a screening and assessment period (including medication washout) prior to randomization into a 16 week double blind treatment period.
Interventions
- DRUG placebo
- DRUG LY2196044
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00804570
The ClinicalTrials.gov registry entry for NCT00804570 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 375 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00804570 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00804570 about?
NCT00804570 is a clinical study titled "A Study for the Treatment of Alcohol Dependence". The Primary objective of this study is to test whether LY2196044 can reduce the number of heavy drinking days per month in people with alcohol dependence. Each subject will undergo a screening and assessment period (including medication washout) prior to randomization into a 16 week double blind tre...
What is the current status of trial NCT00804570?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 375 participants. The study started on 2008-11. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00804570?
The interventions under investigation include: placebo (DRUG), LY2196044 (DRUG).
Who is sponsoring clinical trial NCT00804570?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.